HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $112.00.

Several research firms have recently issued reports on HQY. Barrington Research restated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Jefferies Financial Group set a $108.00 target price on shares of HealthEquity in a research note on Thursday, February 19th. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Monday, January 19th. Finally, Barclays decreased their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th.

HealthEquity Stock Performance

HQY stock opened at $79.96 on Friday. HealthEquity has a twelve month low of $72.76 and a twelve month high of $116.65. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a market cap of $6.83 billion, a P/E ratio of 36.68, a price-to-earnings-growth ratio of 1.01 and a beta of 0.26. The business’s fifty day moving average is $83.57 and its 200-day moving average is $90.85.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the prior year, the company posted $0.78 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. Equities research analysts forecast that HealthEquity will post 2.32 EPS for the current year.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Several large investors have recently made changes to their positions in the stock. Xponance Inc. lifted its position in HealthEquity by 0.8% in the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after acquiring an additional 102 shares in the last quarter. Advisors Asset Management Inc. raised its stake in shares of HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after purchasing an additional 110 shares during the period. Truist Financial Corp lifted its holdings in shares of HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co boosted its position in shares of HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after buying an additional 120 shares during the period. Finally, Larson Financial Group LLC grew its holdings in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.